Neurosurgeon Dr. Chirag Patil attended White House’s Precision Medicine Initiative Summit: 4 points

Chirag Patil, MD, was selected by the Obama Administration to participate in its Precision Medicine Initiative Summit on Feb. 26, in Washington, D.C., according to a Health News Digest report.

Advertisement

Here are four points:

 

1. Dr. Patil is an assistant professor of neurosurgery and director of the Center for Neurosurgical Outcomes Research at Cedars-Sinai Medical Center in Los Angeles.

 

2. His clinical interests include brain tumors, Cushing’s disease, spine tumors, spine surgery and stereotactic radiosurgery.

 

3. His research centers on novel brain tumor therapies and precision medicine. He also has an interest in spine surgery outcome studies.

 

4. He was asked to lend his expertise at the summit, which will include remarks by the president, patient stories and roundtable discussions regarding precision medicine initiatives.

 

More articles on spine:
5 key notes on ocular radiation exposure during minimally invasive spine surgery
Dr. Fred Sweet serves visiting professor to University of Pennsylvania — 5 observations
The race to the White House: Spine surgeons weigh in on candidates’ healthcare strategy

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 4 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in Spine

Advertisement

Comments are closed.